Stock Scorecard



Stock Summary for Ardelyx Inc (ARDX) - $5.54 as of 12/3/2024 11:14:58 AM EST

Total Score

13 out of 30

Safety Score

30 out of 100

Currently on the following lists
Small Cap Stock List
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for ARDX

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ARDX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ARDX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ARDX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ARDX (30 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 1
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0

Latest News for for ARDX

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference - Ardelyx ( NASDAQ:ARDX ) 11/20/2024 1:00:00 PM
Ardelyx Responds to District Court Decision Granting Motion to Dismiss - Ardelyx ( NASDAQ:ARDX ) 11/8/2024 5:31:00 PM
Ardelyx Responds to District Court Decision Granting Motion to Dismiss 11/8/2024 5:31:00 PM
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference - Ardelyx ( NASDAQ:ARDX ) 11/5/2024 1:00:00 PM
Ardelyx ( ARDX ) Reports Break-Even Earnings for Q3 10/31/2024 9:15:00 PM
Ardelyx Beats Q3 Sales Estimates, Shares Climb - Ardelyx ( NASDAQ:ARDX ) 10/31/2024 8:52:00 PM
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View 10/31/2024 1:37:00 PM
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates 10/31/2024 1:32:00 PM
Zoetis ( ZTS ) Reports Next Week: Wall Street Expects Earnings Growth 10/28/2024 2:01:00 PM
Earnings Preview: Ardelyx ( ARDX ) Q3 Earnings Expected to Decline 10/24/2024 2:01:00 PM

Financial Details for ARDX

Company Overview

Ticker ARDX
Company Name Ardelyx Inc
Country USA
Description Ardelyx, Inc., a biopharmaceutical company, develops and sells drugs for the treatment of kidney and cardiorenal diseases in the United States and internationally. The company is headquartered in Fremont, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 9/30/2024
Next Earnings Date 2/20/2025

Stock Price History

Last Day Price 5.54
Price 4 Years Ago 6.47
Last Day Price Updated 12/3/2024 11:14:58 AM EST
Last Day Volume 4,078,626
Average Daily Volume 4,969,177
52-Week High 10.13
52-Week Low 4.34
Last Price to 52 Week Low 27.65%

Valuation Measures

Trailing PE N/A
Industry PE 22.17
Sector PE 42.52
5-Year Average PE -14.21
Free Cash Flow Ratio 6.93
Industry Free Cash Flow Ratio 12.01
Sector Free Cash Flow Ratio 28.39
Current Ratio Most Recent Quarter 4.03
Total Cash Per Share 0.80
Book Value Per Share Most Recent Quarter 0.67
Price to Book Ratio 8.48
Industry Price to Book Ratio 5.02
Sector Price to Book Ratio 20.73
Price to Sales Ratio Twelve Trailing Months 5.35
Industry Price to Sales Ratio Twelve Trailing Months 82.55
Sector Price to Sales Ratio Twelve Trailing Months 24.67
Analyst Buy Ratings 8
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 236,854,000
Market Capitalization 1,312,171,160
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 1.70%
Reported EPS 12 Trailing Months -0.32
Reported EPS Past Year -0.18
Reported EPS Prior Year -0.30
Net Income Twelve Trailing Months -72,583,000
Net Income Past Year -66,067,000
Net Income Prior Year -67,207,000
Quarterly Revenue Growth YOY 74.20%
5-Year Revenue Growth 115.19%
Operating Margin Twelve Trailing Months 0.02

Balance Sheet

Total Cash Most Recent Quarter 190,402,000
Total Cash Past Year 184,299,000
Total Cash Prior Year 123,909,000
Net Cash Position Most Recent Quarter 89,695,000
Net Cash Position Past Year 134,477,000
Long Term Debt Past Year 49,822,000
Long Term Debt Prior Year 26,711,000
Total Debt Most Recent Quarter 100,707,000
Equity to Debt Ratio Past Year 0.77
Equity to Debt Ratio Most Recent Quarter 0.61
Total Stockholder Equity Past Year 166,816,000
Total Stockholder Equity Prior Year 98,329,000
Total Stockholder Equity Most Recent Quarter 158,297,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -63,798,000
Free Cash Flow Per Share Twelve Trailing Months -0.27
Free Cash Flow Past Year -90,061,000
Free Cash Flow Prior Year -70,099,000

Options

Put/Call Ratio 0.35
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.09
MACD Signal -0.20
20-Day Bollinger Lower Band 4.95
20-Day Bollinger Middle Band 5.88
20-Day Bollinger Upper Band 6.81
Beta 0.91
RSI 56.27
50-Day SMA 6.86
150-Day SMA 3.96
200-Day SMA 4.01

System

Modified 12/2/2024 5:57:17 PM EST